Latest news
Loading news…
Uniogen
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Turku, Western Finland, Finland Founded 2022 101-250 employees For Profit
Uniogen is a biotech company that specializes in rapid GenomEra PCR tests, cancer diagnostics, and Upcon labeling technology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
8
Patents
10
15 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 10
- Trademarks
- 15
- Top patent class
- Testing
- IT spend
- $702K
Company Info
- Founded
- 2022
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 4
- HQ
- Turku, Western Finland, Finland
- Region
- European Union (EU), Nordic Countries, Scandinavia
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 0.9
- Trend (90d)
- 5
Acquisitions by Uniogen
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Uniogen
CEO
8
professional contacts at Uniogen
Contact execs at Uniogen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Uniogen
Loading news…
FAQs about Uniogen
People who checked this page also checked these
Browse the full Acquirezy directory.